Dr. Andy Roberts, speaking March 11 at the National Horsemen's Benevolent and Protective Association's convention, said an out-of-competition rule approved by the Association of Racing Commissioners International could have unintended impact.
The Kentucky Equine Drug Research Council, on a 4-2 vote Dec. 3, recommended the Kentucky Horse Racing Commission adopt the national uniform medication rules for Thoroughbred racing.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A public hearing designed to gauge public opinion about a proposal to permit "Instant Racing" type wagering in Kentucky became a faceoff between representatives of the state's horse industry and the Family Foundation.
The Kentucky Horse Racing Authority, acting on advice from the Equine Drug Research Council, unanimously approved medication withdrawal guidelines and threshold levels at a special meeting Feb. 10.
Most Popular Stories
- Unique Bella Sidelined Due to Shin Issue
- Classic Empire to Arkansas Derby After Impressive Work
- Arrogate Last to First in Dubai World Cup
- McCraken, Gunnevera Top Kentucky Derby Future Wager
- Tepin Refuses to Work March 27 at Palm Meadows
- Steve Haskin's Derby Dozen - March 28, 2017
- Tapit Colt Tops Barretts Hips to Watch
- Arrogate and How We Define Greatness
- Skychai Racing Purchases Interest in Fast and Accurate
- Tumblebrutus Gets 25th Black-Type Winner